Skip to main content
. 2017 Feb 2;3(1):6–11. doi: 10.1192/bjpo.bp.116.003756

Table 2. Metabolite concentrations (mmol/kgww ± standard deviations) with statistical comparisons for a voxel in the ACC.

ACC
HC MDD Schizophrenia P(HC-MDD) P(HC-SZ) P(MDD-SZ)
Glu 10.0 (1.3) 10.4 (0.7) 10.7 (1.2) 0.354 0.064 0.363
Gln 2.0 (0.5) 1.9 (0.7) 2.0 (1.0) 0.592 0.385 0.408
Gly 0.9 (0.3) 1.0 (0.2) 0.9 (0.2) 0.234 0.837 0.184
Gsh 1.3 (0.4) 1.2 (0.2) 1.4 (0.4) 0.334 0.303 0.060
Tau 1.6 (0.3) 1.6 (0.4) 1.7 (0.4) 0.671 0.484 0.284
Asp 2.8 (1.5) 2.1 (1.2) 2.9 (1.3) 0.134 0.925 0.128
Myo 8.0 (0.8) 7.2 (0.7) 8.4 (1.3) 0.009 0.327 0.002
Scy 0.5 (0.2) 0.4 (0.1) 0.6 (0.2) 0.026 0.406 0.004
Asc 1.1 (0.4) 1.1 (0.7) 1.4 (0.7) 0.984 0.237 0.249
TCH 2.4 (0.3) 2.4 (0.2) 2.4 (0.3) 0.805 0.792 0.625
TCR 8.9 (1.0) 8.9 (0.7) 9.5 (1.0) 0.929 0.052 0.075
TNAA 11.0 (1.4) 11.5 (0.6) 11.6 (0.8) 0.236 0.107 0.673

AC, anterior cingulate cortex; HC, healthy controls; MDD, major depressive disorder; SZ, schizophrenia; Glu, glutamate; Gln, glutamine; Gly, glycine; Gsh, glutathione; Tau, taurine; Asp, aspartate; Myo, myo-inositol; Scy, scyllo-inositol; Asc, ascorbate; TCH, total choline; TCR, total creatine; TNAA, total NAA. Bolded values indicate statistical significance (alpha<0.05/2, one-tailed, for Myo; alpha<0.05/3, two-tailed, for Scy).